We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

By LabMedica International staff writers
Posted on 22 Mar 2015
Print article
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).
Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening.

Drug discovery and development have long been hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing. A fundamental problem in this inefficient process is that non-human animal models cannot adequately represent human biology.

To circumvent the physiological differences inherent in animal model systems, investigators at the University of California, Berkeley (USA) developed a human tissue-based model system using heart cells derived from selectively manipulated human pluripotent stem cells. The cells were induced to grow in a silicon chip device that contained a three-dimensional culture scaffold that was comparable to the geometry and spacing of connective tissue fiber in a human heart. Heart cells were loaded into the chip in multiple layers aligned in a single direction. Microfluidic channels on either side of the growth area served as models for blood vessels, mimicking the exchange by diffusion of nutrients and drugs with human tissue.

Results published in the March 9, 2015, edition of the journal Scientific Reports revealed that within 24 hours after the heart cells were loaded onto the chip, they began beating on their own at a normal physiological rate of 55 to 80 beats per minute. The culture system was able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional over a period of several weeks.

The system was tested by monitoring the reaction of the heart cells to four different cardiovascular drugs: isoproterenol, E-4031, verapamil, and metoprolol. Changes in the heart tissue’s beat rate were monitored to gauge the response to the compounds. The experiment was considered to be a success when—after half an hour of exposure to isoproterenol, a drug used to treat bradycardia—the heart tissue beat rate increased from 55 to 124 beats per minute.

The "heart-on-a-chip" project was sponsored in part by the [US] National Institutes of Health's Tissue Chip for Drug Screening Initiative, an interagency collaboration for the development of three-dimensional human tissue chips that model the structure and function of human organs.

“Ultimately, these chips could replace the use of animals to screen drugs for safety and efficacy,” said senior author Dr. Kevin E. Healy, professor of bioengineering at the University of California, Berkeley. “Using a well-designed model of a human organ could significantly cut the cost and time of bringing a new drug to market.”

Related Links:
University of California, Berkeley


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.